Various Radiopharmaceuticals

The Department of the Army, via the W40M MRC0 West office, is soliciting quotes for various radiopharmaceuticals to support Brooke Army Medical Center at JBSA Fort Sam Houston in Texas. This requirement is classified under NAICS 325412, Pharmaceutical Preparation Manufacturing, and PSC 6505, Drugs and Biologicals. The government intends to award a firm-fixed-price indefinite delivery indefinite quantity contract featuring a one-year ordering period. There is no set-aside designated for this procurement, as indicated by the code NONE.

The scope of work includes the delivery of radiopharmaceuticals, with specific updates to the statement of work regarding the delivery timeframe for Ioflupane. Recent amendments to solicitation W81K0025QA125 have incorporated a post-award conference to satisfy the contract's minimum guarantee and adjusted the ordering period duration. Nine attachments accompany the notice, including the revised statement of work and multiple solicitation amendments issued between September 2 and September 11, 2025.

Performance is scheduled to occur in Fort Sam Houston, Texas, beginning October 1, 2025, and continuing through September 30, 2030. Responses to this solicitation must be submitted to the point of contact, Jaclyn Evans, by the deadline of September 12, 2025, at 4:00 PM CST. All deliverables and services must adhere to the requirements specified in the primary solicitation document and the associated amendments.